{
    "eid": "2-s2.0-85092689621",
    "title": "Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy",
    "cover-date": "2020-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Amino terminal of type III procollagen peptide",
        "Direct-acting antiviral",
        "Hepatitis C",
        "Liver fibrosis",
        "Vitamin D"
    ],
    "authors": [
        "Supachaya Sriphoosanaphan",
        "Kessarin Thanapirom",
        "Sirinporn Suksawatamnuay",
        "Panarat Thaimai",
        "Sukanya Sittisomwong",
        "Kanokwan Sonsiri",
        "Nunthiya Srisoonthorn",
        "Nicha Teeratorn",
        "Nattaporn Tanpowpong",
        "Bundit Chaopathomkul",
        "Sombat Treeprasertsuk",
        "Yong Poovorawan",
        "Piyawat Komolmit"
    ],
    "citedby-count": 3,
    "ref-count": 37,
    "ref-list": [
        "Vitamin D deficiency",
        "Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels",
        "D-livering the message: the importance of vitamin D status in chronic liver disease",
        "A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response",
        "An update on vitamin D and human immunity",
        "Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline",
        "Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C",
        "Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease",
        "Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study",
        "EASL recommendations on treatment of hepatitis C 2018",
        "Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis",
        "Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy",
        "Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy",
        "Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy",
        "Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline",
        "Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C",
        "Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study",
        "EASL recommendations on treatment of hepatitis C",
        "Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase",
        "CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo",
        "Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis trial",
        "Regional variation and determinants of vitamin D status in sunshine-abundant Thailand",
        "Common genetic determinants of vitamin D insufficiency: a genome-wide association study",
        "Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: a multicenter study",
        "Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients",
        "Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients",
        "Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: a systematic review and meta-analysis",
        "Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis",
        "Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis",
        "Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: a randomised double-blinded, placebo-control trial",
        "Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats",
        "Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: a randomized, double-blind, placebo-controlled study",
        "Morphometry confirms fibrosis regression from sustained virologic response to direct-acting antivirals for hepatitis C",
        "Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience",
        "Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage",
        "Liver stiffness diminishes with antiviral response in chronic hepatitis C",
        "Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "Department of Medicine, Center of Excellence in Liver Diseases",
        "Thai Association",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Science and Technology Development Agency"
    ]
}